ETF Update: Health Care Legislation and Drug Stocks

Health Reform legislation seems to be assured of passage.  As I have suggested in past articles, all viewpoints are represented aggressively.  It is leading to a compromise that will not be loved by anyone, but will constitute a major policy change. The Democrats, dealing with the known bottleneck of averting a Senate filibuster, have made […]

Read More

ETF Update: The Home Stretch for Health Care

Health reform has been the big headline for the first year of the Obama Administration.  It is a major policy objective for Democrats.  It is the hot-button issue for Republicans. For investors, there are many possible impacts.  On today's Meet the Press, Jim Cramer opined that job creation had been stalled because business did not […]

Read More

Health Care Legislation: Our Prognosis

There is an interesting development in the health care debate.  Action by the opponents of health care reform may actually be counter-productive to their avowed interests. Background From my perspective, trying to help investors, the analysis of health care legislation has not been very good.  Most analysts were slow to grasp the fact that many […]

Read More